Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr 13;129(15):2092-2102.
doi: 10.1182/blood-2016-09-687871. Epub 2017 Feb 8.

The GATA factor revolution in hematology

Koichi R Katsumura  1 , Emery H Bresnick  1 ; GATA Factor Mechanisms Group
Collaborators, Affiliations
Review

The GATA factor revolution in hematology

Koichi R Katsumura et al. Blood. .

Abstract

The discovery of the GATA binding protein (GATA factor) transcription factor family revolutionized hematology. Studies of GATA proteins have yielded vital contributions to our understanding of how hematopoietic stem and progenitor cells develop from precursors, how progenitors generate red blood cells, how hemoglobin synthesis is regulated, and the molecular underpinnings of nonmalignant and malignant hematologic disorders. This thrilling journey began with mechanistic studies on a β-globin enhancer- and promoter-binding factor, GATA-1, the founding member of the GATA family. This work ushered in the cloning of related proteins, GATA-2-6, with distinct and/or overlapping expression patterns. Herein, we discuss how the hematopoietic GATA factors (GATA-1-3) function via a battery of mechanistic permutations, which can be GATA factor subtype, cell type, and locus specific. Understanding this intriguing protein family requires consideration of how the mechanistic permutations are amalgamated into circuits to orchestrate processes of interest to the hematologist and more broadly.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
GATA-1 and GATA-2 protein attributes. (A) GATA-1 and GATA-2 protein attributes. N- and C-zinc fingers and posttranslational modification sites are indicated.,,, ,,,,,- (B) Amino acid sequence alignment of human GATA-1 and GATA-2. Protein domains and posttranslational modification sites are highlighted.
Figure 2.
Figure 2.
GATA factor mechanistic principles. (A) GATA switch model. GATA switches involve replacement of one GATA factor by another at a chromatin target site. GATA switches can be associated with an altered transcriptional output. The GATA switch is illustrated at the Gata2 locus. In erythroblasts, friend of GATA-1 (FOG-1) promotes GATA-1-mediated replacement of chromatin-bound GATA-2, instigating repression., (B) Coregulator dependency matrix model. “Sensitive” and “insensitive” denote whether reductions in the endogenous coregulators impact expression of the GATA-1 target genes. Distinct coregulator ensembles mediate GATA-1-dependent transcription in a locus-specific and context-dependent manner.,,,
Figure 3.
Figure 3.
Emerging GATA factor-dependent mechanistic circuits. (A) Ras-MAPK signaling controls GATA-2 activity. (B) GATA-2-GPR65 circuit negatively regulates hematopoiesis. (C) GATA-1-heme circuit regulates erythroid differentiation. (D) GATA-1-FoxO3-exosome circuit controls erythroid maturation., FFL, feed forward loop.
Figure 4.
Figure 4.
GATA-2 mutations in human hematologic disorders inform GATA factor mechanisms. (A) Left, GATA-2 N-finger mutations in human AML patients with biallelic CEBPA mutations.-,, V296 corresponds to GATA-1 V205, which enhances GATA-1 and FOG-1 binding. Right, C-finger mutations identified in AML-associated diseases.-,,- T354M is a loss-of-function mutation that inhibits chromatin occupancy and target gene activation., L359V was identified in chronic myeloid leukemia. (B) Mutations at and near the +9.5 GATA switch site enhancer in pediatric MDS and MonoMAC syndrome.,, del, deletion; ins, insertion.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Evans T, Felsenfeld G. The erythroid-specific transcription factor Eryf1: a new finger protein. Cell. 1989;58(5):877-885. - PubMed
    1. Tsai SF, Martin DI, Zon LI, D’Andrea AD, Wong GG, Orkin SH. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature. 1989;339(6224):446-451. - PubMed
    1. Yamamoto M, Ko LJ, Leonard MW, Beug H, Orkin SH, Engel JD. Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. Genes Dev. 1990;4(10):1650-1662. - PubMed
    1. Zon LI, Mather C, Burgess S, Bolce ME, Harland RM, Orkin SH. Expression of GATA-binding proteins during embryonic development in Xenopus laevis. Proc Natl Acad Sci USA. 1991;88(23):10642-10646. - PMC - PubMed
    1. Dorfman DM, Wilson DB, Bruns GA, Orkin SH. Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. J Biol Chem. 1992;267(2):1279-1285. - PubMed

Publication types

MeSH terms